2134-36-3

Basic information

• Product Name: ETHYL 4-CHLORO-2-METHYLPYRIMIDINE-5-CARBOXYLATE
• Synonyms: ETHYL 4-CHLORO-2-METHYLPYRIMIDINE-5-CARBOXYLATE;Ethyl 4-chloro-2-Methylpy...;4-Chloro-2-Methyl-pyriMidine-5-carboxylic acid ethyl ester;Ethyl 4-chloro-2-methyl-5-pyrimidinecarboxylate;methyl 4-chloro-2-methylpyrimidine-5-carboxylate
• CAS NO: 2134-36-3
• Molecular Formula: C₈H₉ClN₂O₂
• Molecular Weight: 200.62
• Mol File: 2134-36-3.mol
• Article Data: 5

Chemical Properties

• Melting Point: 31 °C
• Boiling Point: 276℃
• Flash Point: 121℃
• Appearance: /
• Density: 1.265
• Vapor Pressure: 0.00487mmHg at 25°C
• Refractive Index: 1.524
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -1.16±0.29(Predicted)
• CAS DataBase Reference: ETHYL 4-CHLORO-2-METHYLPYRIMIDINE-5-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-CHLORO-2-METHYLPYRIMIDINE-5-CARBOXYLATE(2134-36-3)
• EPA Substance Registry System: ETHYL 4-CHLORO-2-METHYLPYRIMIDINE-5-CARBOXYLATE(2134-36-3)

Safety Data

• Hazardous Substances Data: 2134-36-3(Hazardous Substances Data)

Usage

General Description

Ethyl 4-Chloro-2-methylpyrimidine-5-carboxylate is a chemical compound with a molecular formula of C8H9ClN2O2. ETHYL 4-CHLORO-2-METHYLPYRIMIDINE-5-CARBOXYLATE, which belongs to the family of Pyrimidines and their derivatives, is not well-studied, therefore, its properties are not fully understood. It is commonly used in the field of scientific research, particularly in the synthesis of other chemicals. Notably, it is a gray or brown solid with an aromatic odor, and its potential health effects or toxicity have not yet been fully explored.

InChI:InChI=1/C8H9ClN2O2/c1-3-13-8(12)6-4-10-5(2)11-7(6)9/h4H,3H2,1-2H3

Upstream product

• 53135-24-3 ethyl 3,4-dihydro-4-oxo-2-methylpyrimidine-5-carboxylate 
• 53135-24-3 ethyl 4-hydroxy-2-methylpyrimidine-5-carboxylate 
• 87-13-8 diethyl 2-ethoxymethylenemalonate 

Downstream Products

• 7389-14-2 2-methyl-4-amino-5-(carboxamidemethyl)pyrimidine 
• 32640-43-0 9-benzyl-2-methyl-8,9-dihydro-7H-pyrimido[4,5-e][1,4]oxazepin-5-one 
• 143618-25-1 2-Methyl-4-{propyl-[2'-(2-trityl-2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-pyrimidine-5-carboxylic acid ethyl ester 
• 143618-34-2 4-{Butyl-[2'-(2-trityl-2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-2-methyl-pyrimidine-5-carboxylic acid ethyl ester 
• 83410-35-9 ethyl 2-methyl-4-phenylethynyl-5-pyrimidinecarboxylate 
• 101251-42-7 2-Methyl-4-hydrazino-5-ethoxycarbonyl-pyrimidin 
• 16146-47-7 ethyl 2-methyl-4-(3-trifluoromethylanilino)pyrimidine-5-carboxylate 
• 141872-09-5 ethyl 2-methyl-4-{N-butyl-N-[(2'-[N-triphenylmethyl-1H-tetrazol-5-yl]biphenyl-4-yl)methyl]amino}pyrimidine-5-carboxylate 
• 1135957-83-3 2-(benzoylmethylene)-7-methyl-2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-one 
• 1135957-82-2 7-amino-8-benzoyl-2-methylpyrido[4,3-d]pyrimidin-5(6H)-one 
• 189745-28-6 5-(chloromethyl)-2-methyl-pyrimidin-4-amine 
• 89640-71-1 2-methyl-6-thioxo-1,6-dihydro-pyrimidine-5-carboxylic acid 
• 698-29-3 2-methyl-4-amino-5-cyanopyrimidine 
• 84332-33-2 4-ethoxy-2-methyl-pyrimidine-5-carboxylic acid (1-ethyl-pyrrolidin-2-ylmethyl)-amide 

Relevant articles and documents

Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors

The action of the aspartyl protease renin is the rate-limiting initial step of the renin-angiotensin-aldosterone system. Therefore, renin is a particularly promising target for blood pressure as well as onset and progression of cardiovascular and renal diseases. New pyrimidine derivatives 5–14 were designed in an attempt to enhance the renin inhibitory activity of compound 3 identified by our previous fragment-based drug design approach. Introduction of a basic amine essential for interaction with the two aspartic acids in the catalytic site and optimization of the S1/S3 binding elements including an induced-fit structural change of Leu114 (‘Leu-in’ to ‘Leu-out’) by a rational structure-based drug design approach led to the discovery of N-(piperidin-3-yl)pyrimidine-5-carboxamide 14, a 65,000-fold more potent renin inhibitor than compound 3. Surprisingly, this remarkable enhancement in the inhibitory activity of compound 14 has been achieved by the overall addition of only seven heavy atoms to compound 3. Compound 14 demonstrated excellent selectivity over other aspartyl proteases and moderate oral bioavailability in rats.

SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281

A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11betaHSD1, processes for making them and pharmaceutical compositions comprising them are also described.

Research on the function of the amino group in cocarboxylase. I. On the cocarboxylase activity of N-methylthiamine pyrophosphate.

-